In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

It has been about a month since the last earnings report for Recursion Pharmaceuticals (RXRX). Shares have added about 6.5% in that time frame, outperforming the S&P 500. But investors have to be ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

The General specializes in auto coverage policies for drivers who are high risk or who have poor credit scores. It offers affordable car insurance with low down payments and is geared toward those who ...

2026 Maine Senate - Collins vs. Platner Pan Atlantic Platner 43, Collins 42 Platner +1 2026 Maine Senate - Collins vs. Mills Pan Atlantic Collins 43, Mills 43 Tie 2026 California Governor - Open ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

Thomas, Kyle A., Julian De Freitas, Peter DiScioli, and Steven Pinker. "Recursive Mentalizing and Common Knowledge in the Bystander Effect." Journal of Experimental Psychology: General 145, no. 5 ...

National General, formerly known as GMAC insurance, sells homeowners insurance as well as RV and auto insurance. Plan coverage with National General ranges from basic to comprehensive. National ...

THE first edition of this admirable and well-known treatise was the single-handed work of Prof. Whittaker, and was published in 1902. Into the second edition, which was published thirteen years later ...

General Aviation News and issues concerning general aviation, specifically airplanes and helicopters powered by piston and alternative engines (i.e., non-turbine powered aircraft). Subjects include ...